Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Nimorazole × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Head and Neck Neoplasms 2 Virus Diseases 1 Tumor Virus Infections 1 Recurrence 1 Pharyngeal Diseases 1 Papillomavirus Infections 1 Otorhinolaryngologic Neoplasms 1 Otorhinolaryngologic Diseases 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1 Laryngeal Diseases 1 Hypoxia 1 DNA Virus Infections 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

pimonidazole 1 fluoromisonidazole 1 alovudine 1 TH 302 1 Radiotherapy 1 Nimorazole 1 Ipilimumab 1 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02661152 2021-04-13

DAHANCA30

Danish Head and Neck Cancer Group

Phase 3 Unknown

Squamous Cell Carcinoma of Head and Neck, Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡